PRESS RELEASE | Basel, Switzerland, April 5, 2022

Versameb AG (“Versameb”), focused on discovering and developing innovative RNA-based drugs, today announces it will present a poster entitled ‘Design of combinatory RNA molecules to simultaneously activate tumor immunity and target several signaling pathways in solid tumors’ on the 11th of April at the American Association of Cancer Research (AACR) Annual Meeting, taking place in New Orleans, USA on the 8 – 13 April 2022.